Title : Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.

Pub. Date : 2016 Mar 14

PMID : 26977879

1 Functional Relationships(s)
Compound Name
Protein Name
1 Moreover, nelfinavir is effective in BRAF and NRAS mutant melanoma cells isolated from patients progressed on MAPK inhibitor (MAPKi) therapy and in BRAF/NRAS/PTEN mutant tumors. Nelfinavir phosphatase and tensin homolog Homo sapiens